4//SEC Filing
Bjork Elisabeth 4
Accession 0001140361-23-031526
CIK 0001281895other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 7:47 PM ET
Size
7.4 KB
Accession
0001140361-23-031526
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-22+25,850→ 25,850 totalExercise: $21.56Exp: 2033-06-22→ Common Stock (25,850 underlying) - Award
Stock Option (Right to Buy)
2023-06-22$13.93/sh+3,590$50,009→ 3,590 totalExercise: $21.56Exp: 2033-06-22→ Common Stock (3,590 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.
- [F2]This option represents a right to purchase a total of 3,590 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001810406
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 7:47 PM ET
- Size
- 7.4 KB